Flmodafinil (CRL-40,940)

• Dry-Fill Capsules
• 30mL Liquid Solution
• 5-Gram Powder

CRL-40,940 appears to function through several pathways: Overall, it is studied as a non-amphetamine wakefulness compound with cognitive-supporting effects.

• Dopamine transporter (DAT) inhibition producing increased extracellular dopamine signaling
• Norepinephrine transporter (NET) modulation contributing to heightened alertness markers
• Histamine and orexin system activation supporting wakefulness and vigilance endpoints
• Glutamate enhancement and GABA downregulation associated with improved cognitive throughput signals in certain model contexts

CRL-40,940 is commonly researched for

• Wakefulness-promoting pathways
• Executive function support
• Motivation and task initiation signals
• Fatigue resistance endpoints
• Attention and sustained focus markers
• Cognitive performance under sleep deprivation models
• Dopaminergic and adrenergic signaling research designs

Possible findings include: Due to its dopaminergic activity, exposure timing is commonly treated as a key variable in research designs.

• Elevated heart rate signals
• Mild anxiety or restlessness observations
• Headache
• Sleep disruption when exposure timing extends into later observation windows
• Appetite suppression
• Increased perspiration markers
• Irritability signals at higher dose designs
• Mild dehydration observations

Synergistic research pairings commonly explored: Combinations typically avoided in research designs: Avoidance is generally driven by overstimulation risk in research designs rather than acute toxicity concerns.

• Bromantane - dopaminergic support without overstimulation signals
• NAD+ precursors - cellular energy optimization endpoints
• MOTS-C - metabolic and mitochondrial synergy designs
• Racetams (Aniracetam, Oxiracetam) - memory and working memory support models
• Semax and Selank - mood stabilization and neuroprotection adjacent designs
• L-Tyrosine and NALT - catecholamine precursor support variables
• Strong dopaminergic stimulants
• High-dose caffeine
• MAO-inhibiting compounds